Pharmaceutical Manufacturing – Diphenhydramine Hydrochloride Capsules

The contract involves the manufacture of 50mg diphenhydramine hydrochloride capsules in bottles of 100 units, adhering strictly to USP quality standards for pharmaceutical products. Packaging must comply with MIL-STD-2073-1E for military-grade preservation and handling, and labeling must meet MMS NO. 1 marking specifications to ensure traceability and compliance with Department of Defense requirements. The work is structured as a subcontract under the Medical Supply Chain Pharm FSA, with the Department of Defense as the overseeing agency, and the NAICS code 325412 confirms the focus on pharmaceutical and medicinal product manufacturing. All production and packaging processes must support long-term storage, logistical readiness, and military medical use. The solicitation was posted on April 30, 2026, with responses due by May 6, 2026, and performance is expected to fulfill specific military medical supply chain needs.